Taro Pharmaceutical Industries Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF93.37 | Buy/Sell | CHF105.00 | 15.26% | 9 | CHF190.51B |
| ALC | Alcon | Outperform |
8
|
CHF80.08 | Buy/Sell | CHF90.64 | 20.97% | 3 | CHF39.59B |
| VTRS | Viatris Inc | Hold |
8
|
$10.98 | Buy/Sell | $11.73 | 9.29% | 5 | $13.32B |
| HIK | Hikma Pharmaceuticals PLC | Outperform |
18
|
£19.78 | Buy/Sell | £28.11 | 47.67% | 9 | £4.42B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$29.83 | Buy/Sell | $44.75 | 34.09% | 0 | $4.19B |
| PBH | Prestige Consumer Healthcare | Outperform |
16
|
$64.65 | Buy/Sell | $71.50 | 13.69% | 3 | $3.55B |
| BHC | Bausch Health Companies | Hold |
15
|
$6.77 | Buy/Sell | $9.50 | 40.32% | 5 | $2.55B |
| AMRX | Amneal Pharmaceuticals | Outperform |
16
|
$6.82 | Buy/Sell | $6.13 | 17.30% | 1 | $2.09B |
| VNDA | Vanda Pharmaceuticals | Outperform |
0
|
$5.48 | Buy/Sell | $4.25 | -4.93% | 0 | $311.94M |